No Images? Click here
Dear Colleagues,
Welcome to the September edition of the Endoscopy International Open newsletter.
Issue 9 of EIO is being released today, and I’m delighted to present some of the topics – among many more:
- Endocuff Vision is safe to use for dysplasia surveillance in patients with ulcerative colitis: a feasibility study
- Comparison of tissue and molecular yield between fine-needle biopsy (FNB) and fine-needle aspiration (FNA): a randomized study
- Detection of minimal mucosal esophageal lesions in non-erosive gastroesophageal reflux disease using optical enhancement plus optical magnification
I hope you enjoy reading the new issue of Endoscopy International Open!
Thierry Ponchon, MD
Editor-in-Chief
Endoscopy International Open
Infection risk mitigation by simplified IFUs
Advert
Duodenoscopes have been long recognized to require precise execution of reprocessing instructions to properly clean and disinfect. According to Beilenhoff, et al. (2018) [1], it is crucial to follow the manufacturer’s Instructions for Use (“IFU”) at all times to make sure the duodenoscopes are properly cleaned. Yet, IFUs are not always easy to follow. Manufacturers will
increasingly need to adapt their instructions to lower the risk of deviation with the aim of mitigating the risk of infection. PENTAX Medical, a division of the HOYA Group, recently started to change their IFUs and explains how. Read more
Endocuff Vision is safe to use for dysplasia surveillance in patients with ulcerative colitis: a feasibility study
Wendy C. Fang, James Haridy, Charlotte Keung, Daniel Van Langenberg, Brian P. Saunders, Mayur Garg
Risk of developing colorectal cancer (CRC) in patients with ulcerative colitis (UC) is estimated at 1.5 to 2.4 times the background population, with most cancers arising from endoscopically visible dysplastic lesions. Surveillance colonoscopy with dye-spray chromoendoscopy is currently recommended for detection and subsequent endoscopic removal of dysplastic lesions in patients with UC. Read more
A prospective trial of CONfocal endomicroscopy in CYSTic lesions of the pancreas: CONCYST-01
Margaret G. Keane, Natascha Wehnert, Miguel Perez-Machado, Giuseppe K. Fusai, Douglas Thorburn, Kofi W. Oppong, Nicholas Carroll, Andrew J. Metz, Stephen P. Pereira
Pancreatic cystic lesions (PCL) have become an increasingly common finding, present in 1.2 % to 2.6 % of patients undergoing abdominal computed tomography (CT) and in up to 13.5 % of patients undergoing magnetic resonance imaging (MRI) for non-pancreatic indications. A PCL has a broad differential diagnosis. In accordance with international and European guidance, patients with PCL that are thought to be malignant or that are at high risk of malignant transformation are referred for immediate surgical resection while other patients undergo regular surveillance with interval imaging. Read more
Gianpiero Manes, Paolo Andreozzi, Barbara Omazzi, Cristina Bezzio, Davide Redaelli, Massimo Devani, Daniela Morganti, Raffaella Reati, Simone Saibeni, Enzo Mandelli, Ilaria Arena, Cesare Hassan, Germana de Nucci
Screening colonoscopy has been shown to reduce incidence of and mortality from colorectal cancer (CRC). In spite of recent methodological and technological advancements, colonoscopy remains an imperfect test because up to 27 % of adenomas are missed, which could be responsible for development of a significant percentage of the interval cancers. Read more
Submit your manuscript today and publish your latest research in EIO!
Americas
customerservice@thieme.com
f:1-212-947-1112
p:1-212-760-0888
Europe, Asia, Africa, Australia
customerservice@thieme.de
f: +49-711-8931-410
India, Bangladesh, Bhutan, Nepal, Pakistan, and Sri Lanka
eproducts@thieme.in
p: +91-120-4556600
 |  |  |  |  |  |
333 Seventh Avenue
New York, NY 10001
United States
emailjournals@thieme.com
